secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2026-06-22T21:45:16+00:00
Accession:  0001171843-26-004224
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics adopts new bylaws establishing exclusive federal forum for Securities Act claims
--------------------------------------------------------------------------------

- Board approved Second Amended and Restated Bylaws effective June 22, 2026.
- New bylaws require Securities Act of 1933 claims to be brought in U.S. District Courts for Delaware or Massachusetts.
- Previous bylaws from July 17, 2020 restated in entirety.
- Change is procedural; no impact on operations or financials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184326004224/0001171843-26-004224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184326004224/f8k_062226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-004224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer